Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery
Press Release 4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery Systematic review and meta-analysis of 149 clinical trials of AAV-based gene...
-
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board Professor of Molecular, Cellular and Developmental Biology and Immunology at Yale UniversityPrincipal investigator at the Howard...
-
Appointment of Professor Akiko Iwasaki to Scientific Advisory Board Professor of Molecular, Cellular and Developmental Biology and Immunology at Yale UniversityPrincipal investigator at the Howard...
-
Press Release 4BIO Capital leads SparingVision’s €44.5 million financing round 21 October 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
-
Press Release 4BIO Capital leads SparingVision’s €44.5 million financing round 21 October 2020 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
-
4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board Professor of Microbiology and Immunology at Keio UniversityBrings extensive experience in gut microbiota, a...
-
4BIO Capital announces appointment of Professor Kenya Honda to Scientific Advisory Board Professor of Microbiology and Immunology at Keio UniversityBrings extensive experience in gut microbiota, a...
-
Press Release 4BIO Capital appoints Brian P. McVeigh as Venture Partner Appointment of seasoned pharma and biotech industry veteran to strengthen 4BIO Capital’s US operations 1 July 2020 LONDON...
-
Press Release 4BIO Capital appoints Brian P. McVeigh as Venture Partner Appointment of seasoned pharma and biotech industry veteran to strengthen 4BIO Capital’s US operations 1 July 2020 LONDON...
-
Press Release 4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin Kyowa Kirin’s first strategic investment into a Venture Capital fund Kyowa Kirin to...